LUCY Innovative Eyewear, Inc. logo

LUCY Innovative Eyewear, Inc.

Healthcare
$1.02+2.93%ClosedMarket Cap: $4.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.76

P/S

1.37

EV/EBITDA

0.03

DCF Value

$-21.04

FCF Yield

-187.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

17.5%

Operating Margin

-300.7%

Net Margin

-272.5%

ROE

-83.4%

ROA

-85.7%

ROIC

-106.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$773.6K$-2.3M$
Q4 null$959.8K$-1.9M$
FY null$2.7M$-7.6M$
Q3 null$668.1K$-1.8M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Gross Harrison R.director, officer: Chief Executive Officer
BuyThu Jan 22
Gayle Oswaldofficer: Chief Financial Officer
BuyThu Jan 15
Gayle Oswaldofficer: Chief Financial Officer
BuyThu Jan 15
Gross Harrison R.director, officer: Chief Executive Officer
BuyMon Jan 12
Gross Harrison R.director, officer: Chief Executive Officer
SellMon Jan 12

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

2.69

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. The company sells its products through various e-commerce and retail distribution channels. Innovative Eyewear, Inc. has a partnership with Lucyd. The company was founded in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd.

Peers